Screener
Eligibility screening
Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared…
74 US sites in AL, AZ, CA, CT +23
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.